Transfer factor – development and research of new pharmaceutical forms (Q11224)

From EU Knowledge Graph
Revision as of 09:12, 28 November 2021 by DG Regio (talk | contribs) (‎Created claim: summary (P836): Le projet présenté aborde la question de la préparation d’une nouvelle forme pharmaceutique d’immunomodulateurs spécifiques basé sur le transfert de facteurs (TF) et les méthodes de test de leur potentiel immunobiologique et., translated_summary)
Jump to navigation Jump to search
Project Q11224 in Czech Republic
Language Label Description Also known as
English
Transfer factor – development and research of new pharmaceutical forms
Project Q11224 in Czech Republic

    Statements

    0 references
    0 references
    24,083,996.56 Czech koruna
    0 references
    963,359.86 Euro
    10 January 2020
    0 references
    43,285,400.0 Czech koruna
    0 references
    1,731,416.0 Euro
    10 January 2020
    0 references
    55.64 percent
    0 references
    16 April 2018
    0 references
    30 April 2020
    0 references
    AUMED, a.s.
    0 references
    0 references

    49°59'56.22"N, 14°25'3.50"E
    0 references
    14300
    0 references
    Předložený projekt řeší problematiku přípravy nové lékové formy specifických imunomodulátorů na bázi transfer faktorů (TF) a metod testování jejich imunobiologického potenciálu a. (Czech)
    0 references
    The submitted project addresses the issue of preparation of a new pharmaceutical form of specific immunomodulators based on the transfer of factors (TF) and methods of testing their immunobiological potential a. (English)
    22 October 2020
    0 references
    Le projet présenté aborde la question de la préparation d’une nouvelle forme pharmaceutique d’immunomodulateurs spécifiques basé sur le transfert de facteurs (TF) et les méthodes de test de leur potentiel immunobiologique et. (French)
    28 November 2021
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/16_083/0010301
    0 references